Literature DB >> 24410981

Reversible basal ganglia lesions in neuropsychiatric lupus: a report of three pediatric cases.

Satoshi Sato1, Junya Nakajima, Masaru Shimura, Hisashi Kawashima, Taku Yoshio, Yuko Hara.   

Abstract

AIM: Central nervous system involvement represents a serious and common complication of systemiclupus erythematosus (SLE). We describe the characteristics of patients with neuropsychiatric (NP) SLE complicated with reversible basal ganglia lesions.
METHODS: We describe the cases of three NPSLE patients.
RESULTS: They presented with NP manifestations such as headache, cognitive dysfunction, tremors, seizures, and mood disorder. The levels of autoantibodies to NMDA (N-methyl-d-aspartate) receptor antibodies and antiribosomal-P antibodies were elevated, indicating the presence of an acute phase. Marked elevation of interleukin-6 in cerebrospinal fluid was noted when these patients showed NP symptoms. Moreover, the patients presented with high-intensity lesions in the basal ganglia on T2-weighted images, fluid-attenuated inversion recovery (FLAIR) images, diffusion-weighted images (DWI) and apparent diffusion coefficient (ADC) maps. Following immunosuppressive treatment, almost complete improvement of the lesions was noted.
CONCLUSION: The reported cases indicate that reversible vasculopathies represent vasogenic edema localized in basal ganglia lesions and that activation of the autoimmune system and inflammation could lead to NP manifestations in SLE.
© 2014 Asia Pacific League of Associations for Rheumatology and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  apparent diffusion coefficient; diffusion-weighted images; lupus; neuropsychiatric systemic lupus erythematosus; normal range 2; posterior reversible encephalopathy syndrome

Mesh:

Substances:

Year:  2014        PMID: 24410981     DOI: 10.1111/1756-185X.12235

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  4 in total

Review 1.  Neurological Disorders Associated with Striatal Lesions: Classification and Diagnostic Approach.

Authors:  Davide Tonduti; Luisa Chiapparini; Isabella Moroni; Anna Ardissone; Giovanna Zorzi; Federica Zibordi; Sergio Raspante; Celeste Panteghini; Barbara Garavaglia; Nardo Nardocci
Journal:  Curr Neurol Neurosci Rep       Date:  2016-06       Impact factor: 5.081

2.  Bilateral reversible basal ganglia changes associated with dystonia and hemifacial spasms in central nervous system lupus.

Authors:  Kit Wu; Loucas Christodoulou; Ata Siddiqui; David D'Cruz; Thomasin Andrews
Journal:  Quant Imaging Med Surg       Date:  2015-12

3.  C1q Deficiency and Neuropsychiatric Systemic Lupus Erythematosus.

Authors:  Rosanne A van Schaarenburg; César Magro-Checa; Jaap A Bakker; Y K Onno Teng; Ingeborg M Bajema; Tom W Huizinga; Gerda M Steup-Beekman; Leendert A Trouw
Journal:  Front Immunol       Date:  2016-12-27       Impact factor: 7.561

4.  Pediatric systemic lupus erythematosus patients in South Africa have high prevalence and severity of cardiac and vascular manifestations.

Authors:  Michael J Harrison; Liesl J Zühlke; Laura B Lewandowski; Christiaan Scott
Journal:  Pediatr Rheumatol Online J       Date:  2019-11-26       Impact factor: 3.054

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.